[Bullous pemphigoid in childhood]

Area of Science:

• Pediatric Dermatology
• Autoimmune Blistering Diseases

Background:

• Bullous pemphigoid (BP) is a rare autoimmune blistering disease typically affecting the elderly.
• Juvenile bullous pemphigoid (JBP) presents unique diagnostic and therapeutic challenges in pediatric populations.

Observation:

• A case of a seven-year-old girl with juvenile bullous pemphigoid is presented.
• The clinical presentation and differential diagnosis from other pediatric bullous dermatoses were discussed.
• The patient's history suggested potential efficacy of erythromycin treatment.

Findings:

• Erythromycin demonstrated potential therapeutic benefits in this case of juvenile bullous pemphigoid.
• Differential diagnosis of bullous diseases in children was explored in relation to the presented case.

Implications:

• This report may inform future investigations into the use of erythromycin for juvenile bullous pemphigoid.
• Understanding JBP's differential diagnosis is crucial for accurate pediatric dermatological management.
• Further research is warranted to explore the theoretical basis and clinical effectiveness of erythromycin in JBP.